Table 1 Clinical and biochemical features of the cases and controls
Cases (diabetics) | Controls (non-diabetic) | p value | |
|---|---|---|---|
Age (years) | 52.2 ± 10.8 | 47.3 ± 10.2 | 0.02 |
BMI (kg/m2) | 24.2 ± 3.1 | 25.4 ± 3.2 | 0.05 |
Waist circumference (cm) | 90.2 ± 8.0 | 92.0 ± 8.9 | 0.28 |
Hip circumference (cm) | 93.5 ± 6.9 | 95.0 ± 7.5 | 0.30 |
Systolic blood pressure (mmHg) | 123.2 ± 16.9 | 123.2 ± 13.9 | 0.98 |
Diastolic blood pressure (mmHg) | 81.5 ± 9.1 | 83.8 ± 10.6 | 0.24 |
Hypertension | 24 (51.1%) | 19 (35.8%) | 0.16 |
Ischaemic heart disease | 18 (38.3%) | 14 (26.4%) | 0.28 |
Stroke | 3 (6.4%) | 5 (9.4%) | 0.72 |
Cirrhosis | 1 (2.1%) | 1 (1.9%) | 0.92 |
Chronic kidney disease | 4 (8.5%) | 2 (3.8%) | 0.42 |
FBS (mg/dL) | 141.3 ± 75.2 | 83.2 ± 25.7 | < 0.001 |
HbA1C (%) | 8.7 ± 2.1 | 5.9 ± 0.89 | < 0.001 |
Total Testosterone (ng/dL) | 554.3 ± 218.6 | 569.5 ± 257.4 | 0.75 |
Free testosterone (ng/dL) | 9.9 ± 7.1 | 12.2 ± 8.9 | 0.15 |
Bio-available testosterone (ng/dL) | 202.2 ± 121.5 | 239.6 ± 148.3 | 0.17 |
SHBG (nmol/L) | 59.9 ± 28.5 | 45.6 ± 23.8 | 0.007 |
FSH (mIU/mL) | 9.8 ± 10.8 | 5.6 ± 6.1 | 0.02 |
LH (mIU/mL) | 7.6 ± 4.3 | 4.7 ± 3.4 | < 0.001 |
Total cholesterol (mg/dL) | 209.6 ± 72.4 | 239.6 ± 69.9 | 0.04 |
LDL (mg/dL) | 133.2 ± 61.4 | 162.5 ± 61.8 | 0.02 |
HDL (mg/dL) | 47.7 ± 13.8 | 45.9 ± 14.7 | 0.54 |
Triglycerides (mg/dL) | 143.0 ± 81.2 | 155.6 ± 76.7 | 0.42 |